U.S. Markets open in 43 hrs, 21 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 17.19 09:42 AM EDT | |
|---|---|---|
| Day High | 17.98 03:50 PM EDT |
|
| Range | 0.79 |
| Volume | 1.79 M | |
|---|---|---|
| 30-Day Avg Vol | 1.72 M |
|
| Difference | 3.92% |
| Market Cap | 2.09 B | |
|---|---|---|
| Mkt Cap Chg | 8.20 M |
| Shares Out | 117.15 M | |
|---|---|---|
| % Shrs Traded | 1.53% | |
| 1yr EPS Est | 2.629 |
| 52-Wk Low | 13.87 10/10/08 | |
|---|---|---|
| 52-Wk High | 26.14 1/2/09 |
|
| Range | 12.27 |
| Prev Close | 17.82 7/1/09 | |
|---|---|---|
| Today's Open | 17.65 | |
| Change | -0.95% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.32 M |
| Revenue (LFY) | 1.26 B | |
|---|---|---|
| Earnings (LFY) | 261.74 M | |
| Earnings (MRQ) | 39.04 M | |
| Next Earn Est | 0.665 | |
| Next Earnings | 07/30/2009 |
|
| EPS (TTM) | 2.01 | |
| 1yr EPS Growth | 4.33% |
| P/E Ratio (TTM) | 8.90 | |
|---|---|---|
| P/E Ratio (Fwd) | 6.80 | |
| PEG Ratio | 0.75 | |
| Return on Equity | 19.50 | |
| Beta | 0.46 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
CNBC Video
Endo Pharmaceuticals wants the pain to end, preferably through the drugs it acquires and markets. The pharmaceutical company has a portfolio of both branded and generic prescription products for pain management. ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.665 7/30/09 | — — |
—
—
|
| Last Quarter | 0.625 3/31/09 | 0.67 3/31/09 |
0.045
Beat
|
| 2 Quarters Ago | 0.586 12/31/08 | 0.69 12/31/08 |
0.104
Beat
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 335.30 M | 1.26 B |
| Gross Profit | 252.29 M | 993.30 M |
| Operating Income | 103.87 M | 395.03 M |
| Net Income | 39.04 M | 261.74 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts